Elizabeth Morgan

Ms. Morgan has more than 30 years of experience in the biotechnology and pharmaceutical industry being well versed in all stages of drug development with a proven track record in recruiting, training, and managing clinical, regulatory, and quality departments. Ms. Morgan has been involved in the successful filing of over 25 INDs, 5 NDAs, and 1 PMA. Recent experience includes NDA/MAA approval of Vabomere™, Minocin, Quinsair ™, and Dermagraft ™. She has experience running over 50 Phase 1-4 clinical trials in multiple indications in respiratory infections, infectious diseases, autoimmune disorders, asthma/allergy, cardiovascular, and skin replacement. She has lead inspection-readiness activities and participated in several successful FDA inspections. Ms. Morgan has held executive positions at The Medicines Company/Rempex, Mpex, Nereus Pharmaceuticals, Hollis Eden, and The Immune Response. Prior to that, she held clinical, regulatory, and quality positions of increasing responsibility at Advanced Tissue Sciences and Dura. Ms. Morgan received her B.S. in Biology from San Diego State University.